P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent: The SHARE Randomized Clinical Trial.
Min PK, Kang TS, Cho YH, Cheong SS, Kim BK, Kwon SW, Park WJ, Lee JH, Kim W, Lee WS, Yoon YW, Lee BK, Kwon HM, Hong BK; SHARE Investigators.
Min PK, et al.
JAMA Netw Open. 2024 Mar 4;7(3):e240877. doi: 10.1001/jamanetworkopen.2024.0877.
JAMA Netw Open. 2024.
PMID: 38451525
Free PMC article.
Clinical Trial.
OBJECTIVE: To investigate whether P2Y12 inhibitor monotherapy after 3 months of DAPT was noninferior to 12 months of DAPT following PCI with a drug-eluting stent. DESIGN, SETTING, AND PARTICIPANTS: The Short-Term Dual Antiplatelet Therapy After Deployment of Bioabsorbable …
OBJECTIVE: To investigate whether P2Y12 inhibitor monotherapy after 3 months of DAPT was noninferior to 12 months of DAPT following PCI with …